Erik Vassella

5.1k total citations
85 papers, 3.9k citations indexed

About

Erik Vassella is a scholar working on Molecular Biology, Epidemiology and Cancer Research. According to data from OpenAlex, Erik Vassella has authored 85 papers receiving a total of 3.9k indexed citations (citations by other indexed papers that have themselves been cited), including 48 papers in Molecular Biology, 33 papers in Epidemiology and 23 papers in Cancer Research. Recurrent topics in Erik Vassella's work include Trypanosoma species research and implications (28 papers), Glioma Diagnosis and Treatment (15 papers) and Biochemical and Molecular Research (15 papers). Erik Vassella is often cited by papers focused on Trypanosoma species research and implications (28 papers), Glioma Diagnosis and Treatment (15 papers) and Biochemical and Molecular Research (15 papers). Erik Vassella collaborates with scholars based in Switzerland, Germany and United Kingdom. Erik Vassella's co-authors include Isabel Roditi, Michael Boshart, Nora Bandi, Barbara Yutzy, Christina Kunz Renggli, Aurel Perren, Ulrich Baumgartner, Matthias S. Dettmer, Adrian B. Hehl and Андреас Каппелер and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nucleic Acids Research and Journal of Clinical Oncology.

In The Last Decade

Erik Vassella

80 papers receiving 3.9k citations

Peers

Countries citing papers authored by Erik Vassella

Since Specialization

Citations

This map shows the geographic impact of Erik Vassella's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Erik Vassella with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Erik Vassella more than expected).

Fields of papers citing papers by Erik Vassella

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Erik Vassella. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Erik Vassella. The network helps show where Erik Vassella may publish in the future.

Co-authorship network of co-authors of Erik Vassella

This figure shows the co-authorship network connecting the top 25 collaborators of Erik Vassella. A scholar is included among the top collaborators of Erik Vassella based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Erik Vassella. Erik Vassella is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Clinically Uncertain Liver Masses: A Guide to Distinguishing Poorly Differentiated Primary Liver Cancer 2025 ·Biomedicines ·(unknown), Michael P. Brönnimann, Erik Vassella, Guido Stirnimann, Matteo Montani, Juliane Friemel	1
2	Methods in cancer research: Assessing therapy response of spheroid cultures by life cell imaging using a cost-effective live-dead staining protocol 2024 ·Biology Methods and Protocols ·(unknown), Erik Vassella	3
3	Non‐Hotspot PIK3CA Variants Have Higher Variant Allele Frequency and are More Common in Syndromic Vascular Malformations 2024 ·American Journal of Medical Genetics Part A ·(unknown), (unknown), (unknown), Yvonne Döring, André Schaller, Erik Vassella, Laurence M. Boon, Iris Baumgärtner, (unknown), Christiane Zweier, Miikka Vikkula, Jochen Rößler	1
4	Cribriform Morular Thyroid Carcinoma – Ultimobranchial Pouch-Related? Deep Molecular Insights of a Unique Case 2023 ·Endocrine Pathology ·Matthias S. Dettmer, (unknown), (unknown), Erik Vassella, Aurel Perren, Corinna Wicke	3
5	Evaluation of MTAP and p16 immunohistochemical deficiency as surrogate marker for CDKN2A/B homozygous deletion in gliomas 2023 ·Pathology ·(unknown), (unknown), (unknown), (unknown), (unknown), Philippe Schucht, Erik Vassella, Ekkehard Hewer	22
6	Effects of formalin fixation on polarimetric properties of brain tissue: fresh or fixed? 2023 ·Neurophotonics ·(unknown), (unknown), (unknown), (unknown), Richard McKinley, Angelo Pierangelo, Tatiana Novikova, Erik Vassella, Philippe Schucht, Ekkehard Hewer, (unknown)	9
7	CNS Antigen-Specific Neuroinflammation Attenuates Ischemic Stroke With Involvement of Polarized Myeloid Cells 2022 ·Neurology Neuroimmunology & Neuroinflammation ·(unknown), Nina Hagemann, (unknown), (unknown), Anke Salmen, Robert Hoepner, Irene Keller, (unknown), Denis Grandgirard, Stephen L. Leib, Erik Vassella, Giuseppe Locatelli, Dirk M. Hermann, Andrew Chan	3
8	Programmed Death-Ligand 1 Expression in Lung Cancer and Paired Brain Metastases—a Single-Center Study in 190 Patients 2022 ·JTO Clinical and Research Reports ·(unknown), (unknown), Christian Fung, (unknown), Ferdinando Cerciello, Evelyn Herrmann, Ekin Ermiş, Ralph A. Schmid, Erik Vassella, Sabina Berezowska	1
9	Tumor Necrosis Factor-α Initiates miRNA-mRNA Signaling Cascades in Obstruction-Induced Bladder Dysfunction 2018 ·American Journal Of Pathology ·(unknown), Ali Hashemi Gheinani, Ulrich Baumgartner, Erik Vassella, Rémy Bruggmann, Fiona C. Burkhard, Katia Monastyrskaya	18
10	Integrated Genomic and Immunophenotypic Classification of Pancreatic Cancer Reveals Three Distinct Subtypes with Prognostic/Predictive Significance 2018 ·Clinical Cancer Research ·Martin Wartenberg, (unknown), Inti Zlobec, Erik Vassella, Serenella Eppenberger‐Castori, Luigi Terracciano, Micha David Eichmann, Mathias Worni, Beat Gloor, Aurel Perren, Eva Karamitopoulou	142
11	Improved isolation strategies to increase the yield and purity of human urinary exosomes for biomarker discovery 2018 ·Scientific Reports ·Ali Hashemi Gheinani, (unknown), Ulrich Baumgartner, Erik Vassella, Annette Draeger, Fiona C. Burkhard, Katia Monastyrskaya	151
12	mTOR mediates a mechanism of resistance to chemotherapy and defines a rational combination strategy to treat KRAS-mutant lung cancer 2018 ·Oncogene ·Shun‐Qing Liang, (unknown), Sabina Berezowska, Thomas M. Marti, Duo Xu, Laurène Froment, Haitang Yang, Sean R. R. Hall, Erik Vassella, Yang Zhang, Gregor J. Kocher, (unknown), Carsten Riether, Adrian F. Ochsenbein, Ralph A. Schmid, Ren‐Wang Peng	45
13	miR-29b Mediates NF-κB Signaling in KRAS-Induced Non–Small Cell Lung Cancers 2016 ·Cancer Research ·(unknown), Ulrich Baumgartner, Stefan Haemmig, (unknown), Stephan Schäfer, Sabina Berezowska, (unknown), Patrick Dorn, Mario P. Tschan, Erik Vassella	48
14	Morphological and molecular characteristics of HER2 amplified urothelial bladder cancer 2015 ·Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin ·(unknown), Erik Vassella, Nora Bandi, Ulrich Baumgartner, Vera Genitsch, Diana Rotzer, Roland Seiler, George N. Thalmann, Achim Fleischmann	40
15	miR-125b controls apoptosis and temozolomide resistance by targeting TNFAIP3 and NKIRAS2 in glioblastomas 2014 ·Cell Death and Disease ·Stefan Haemmig, Ulrich Baumgartner, (unknown), S Zbinden, Mario P. Tschan, Андреас Каппелер, Luigi Mariani, István Vajtai, Erik Vassella	69
16	miR-15a and miR-16 Are Implicated in Cell Cycle Regulation in a Rb-Dependent Manner and Are Frequently Deleted or Down-regulated in Non–Small Cell Lung Cancer 2009 ·Cancer Research ·Nora Bandi, (unknown), Mathias Gugger, Marlène Arnold, Verena Kocher, Lara Hasan, Андреас Каппелер, Thomas Brunner, Erik Vassella	312
17	Objective Response to Radiation Therapy and Long-Term Survival of Patients with WHO Grade II Astrocytic Gliomas with Known LOH 1p/19q Status 2007 ·Strahlentherapie und Onkologie ·Ali-Reza Fathi, Erik Vassella, Marlène Arnold, Jürgen Curschmann, Michael Reinert, István Vajtai, Joachim Weis, Gianluca Deiana, Luigi Mariani	8
18	Expression of a Major Surface Protein ofTrypanosoma bruceiInsect Forms Is Controlled by the Activity of Mitochondrial Enzymes 2004 ·Molecular Biology of the Cell ·Erik Vassella, (unknown), André Schneider, Erwin Studer, Christina Kunz Renggli, Isabel Roditi	52
19	Stage-specific Requirement of a Mitogen-activated Protein Kinase byTrypanosoma brucei 2002 ·Molecular Biology of the Cell ·Ingrid Müller, (unknown), Isabel Roditi, Erik Vassella	54
20	Glycosylphosphatidylinositol-anchored surface molecules of Trypanosoma congolense insect forms are developmentally regulated in the tsetse fly 2002 ·Molecular and Biochemical Parasitology ·Peter Bütikofer, Erik Vassella, (unknown), Christina Kunz Renggli, Reto Brun, Terry W. Pearson, Isabel Roditi	33

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact